Published in:
01-07-2003 | Brief Report
Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage
Published in: Intensive Care Medicine | Issue 7/2003
Login to get accessAbstract
Objective
Magnesium sulfate is being investigated for the prevention or treatment of vasospasm following subarachnoid hemorrhage.
Patient
A 45-year-old woman suffered subarachnoid hemorrhage and developed after 8 days symptomatic vasospasm in the left middle cerebral artery (MCA) while she was receiving nimodipine prophylactically.
Methods and results
Transcranial Doppler monitoring was performed. Cerebral autoregulation was abolished in the left MCA. Despite this finding the administration of a bolus dose of MgSO4, followed by a continuous infusion in order to achieve serum magnesium levels in the range of 4–4.5 mg/dl (1.65–1.85 mmol/l), resulted in a marked decrease (12.2%) of the left MCA mean blood flow velocity, without clinically relevant change in systemic blood pressure (3%). This effect was maintained for at least 4 h. It did not prevent the development of ischemic lesions.